DNAprint Genomics (DNAG)

[Blue Juggernaut]

We are on the brink of possible mass dilution for the next several years and there are those that predict MAJOR new. We’ve been down this road before and most know how I feel about that. Look, we had major news today that was good and bad. The bad part is that we may/likely have to destroy the value of our common stock to keep the company alive (one of the safer choices would have been to increase shares proportionally to a two year need. With products in the pipeline the need could change if pps increase along with earnings but too late to discuss that). The good news is that the company could be around long enough to see S-EPO come to market. …but there are so many questions to ask that I have not heard answers for nor have I heard anyone at the meeting address them. Such as Trace…At the meeting did anyone ask serious questions about Trace? We bought a company that generated ~250K in rev. in 04 but were the earnings negative? We have not heard about Trace’s earnings. This begs the question, where the earnings negative? ..and if so, there is NO good reason to buy a company that is losing money other than patents or proprietary tech and I have not heard about that either. It’s simple, now that we have a r/s coming the 10 news points that I want to hear about are: 1) A major deal with big pharma; 2) Major progress reports on EPO; 3) The m&a of a company that MAKES a profit; 4) A patent getting approved and appeals on the final rejections; 5) Major cost reductions to become profitable; 6) Any development of new science within the company; 7) The reduction of available shares to go outstanding; 8) Getting on one of the major exchanges; 9) FINALLY get one of the tests to market; 10) and a pr that states that they have their first profitable qtr.. Perfidiousness? No. Questions do not equal disloyalty and all of us should have serious questions.

Big Blue